Escin
Escin structure
|
Common Name | Escin | ||
|---|---|---|---|---|
| CAS Number | 6805-41-0 | Molecular Weight | 2262.51000 | |
| Density | 1.46 g/cm3 | Boiling Point | 1140.6ºC at 760 mmHg | |
| Molecular Formula | C55H86O24 | Melting Point | 224.5°C | |
| MSDS | Chinese USA | Flash Point | 311.8ºC | |
| Symbol |
GHS07 |
Signal Word | Warning | |
|
Effect of beta-aescin extract from Chinese buckeye seed on chronic venous insufficiency.
Pharmazie 68(6) , 428-30, (2013) The aim of this study was to explore the mechanism of domestic beta-aescin treating chronic venous insufficiency through observing its actions on the isolated canine saphenous venous tension, venous pressure, venous return and lymphatic return. The isolated c... |
|
|
Interaction between titanium and cadmium in various guinea pig organs.
Biol. Trace Elem. Res. 151(2) , 209-16, (2013) Titanium (Ti) is used in many fields, while cadmium (Cd) is known to cause the itai-itai disease. In the present study, possible interactions between titanium and cadmium were investigated. Aorta, taenia coli, and liver were removed from male guinea pigs. Mus... |
|
|
Rho-kinase inhibition attenuates calcium-induced contraction in β-escin but not Triton X-100 permeabilized rabbit femoral artery.
J. Muscle Res. Cell Motil. 32(2) , 77-88, (2011) K+-depolarization (KCl) of smooth muscle has long been known to cause Ca2+-dependent contraction, but only recently has this G protein-coupled receptor (GPCR)-independent stimulus been associated with rhoA kinase (ROCK)-dependent myosin light chain (MLC) phos... |
|
|
Bioavailability of l-thyroxine and its metabolites after topical treatment with an emulsion containing 0.1% micronised l-thyroxine.
G. Ital. Dermatol. Venereol. 148(3) , 287-92, (2013) Aim of the study was to assess systemic effects of a cycle of treatment with a topical formulation of l-T4 and escin (Somatoline®) in healthy women based on changes in bioavailability of FT4, FT3, rT3, and TSH.This study enrolled 20 healthy adult women with b... |
|
|
[Efficacy of the anti-edema drug L-lysine aescinat in stroke].
Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 112(12 Pt 2) , 31-4, (2012) Forty-nine patients with ischemic hemispheric stroke admitted within 48 hours of stroke onset were studied. Twenty-nine patients (the main group) received L-lysine aescinat as an anti-edema drug. The efficacy was evaluated clinically and by EEG and autonomic ... |
|
|
Mixture designs in the optimisation of PLGA nanoparticles: influence of organic phase composition on β-aescin encapsulation.
J. Microencapsul. 29(2) , 115-25, (2012) The objective of this study was to enhance the encapsulation of the antileishmanial saponin aescin in poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles (NPs). We prepared the NPs by the O/W and W/O/W combined emulsification solvent evaporation/salting-out t... |
|
|
[Effects of sodium aescinate on lipid peroxidiation injury induced by intestinal ischemia/reperfusion].
Zhongguo Ying Yong Sheng Li Xue Za Zhi 27(1) , 17-8, 97, (2011)
|
|
|
[The pharmacology of escin, a saponin of Aesculus hippocastanum L. III. Pharmacokinetics and toxicology].
Boll. Chim. Farm. 131(8) , 320-1, (1992)
|
|
|
[Pharmacology of escin, a saponin of Aesculus hippocastanum L. II. Pharmacodynamics of escin. Chapter II].
Boll. Chim. Farm. 131(7) , 284-93, (1992)
|
|
|
[Pharmacology of escin, a saponin from Aesculus hyppocastanum L. II. Pharmacodynamics of escin. Chapter I].
Boll. Chim. Farm. 131(6) , 242-6, (1992)
|